549 Pill - green capsule/oblong, 16mm
Pill with imprint 549 is Green, Capsule/Oblong and has been identified as Memantine Hydrochloride Extended Release 28 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Memantine is used in the treatment of Alzheimer's Disease and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Memantine 28 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 549
Memantine Hydrochloride Extended Release
- Imprint
- 549
- Strength
- 28 mg
- Color
- Green
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- Manufacturer
- Cadila Healthcare Limited
- National Drug Code (NDC)
- 68382-0549
- Inactive Ingredients
-
ammonia,
alcohol,
butyl alcohol,
ethylcellulose (7 mPa.s),
ferrosoferric oxide,
FD&C Blue No. 2,
ferric oxide yellow,
gelatin,
hypromelloses,
isopropyl alcohol,
potassium hydroxide,
propylene glycol,
shellac,
sodium lauryl sulfate,
sucrose,
magnesium silicate,
triethyl citrate,
titanium dioxide,
water
Note: Inactive ingredients may vary.
Related images for "549"
More about memantine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (90)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous central nervous system agents
- En español
Patient resources
- Memantine drug information
- Memantine (Advanced Reading)
- Memantine Tablets
- Memantine Extended-Release Capsules
- Memantine Solution
Other brands
Professional resources
- Memantine monograph
- Memantine (FDA)
- Memantine ER Tablets (FDA)
- Memantine ER capsules (FDA)
- Memantine Oral Solution (FDA)
- Memantine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
